Marianne P. Allen

Array ( [id] => 5515382 [patent_doc_number] => 20090215689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'FGF2-BINDING PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/161950 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11756 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215689.pdf [firstpage_image] =>[orig_patent_app_number] => 12161950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651000 [patent_doc_number] => 20080038256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'ANTI-HGF/SF HUMANIZED ANTIBODY AND METHOD FOR THE PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 11/626055 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6419 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038256.pdf [firstpage_image] =>[orig_patent_app_number] => 11626055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220009 [patent_doc_number] => 20100055104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'THERAPEUTIC COMPOSITION COMPRISING AN INHIBITOR OF AN HSP 90 PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/159935 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10900 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055104.pdf [firstpage_image] =>[orig_patent_app_number] => 12159935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5080859 [patent_doc_number] => 20070124083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them' [patent_app_type] => utility [patent_app_number] => 11/645289 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 118 [patent_figures_cnt] => 118 [patent_no_of_words] => 16493 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20070124083.pdf [firstpage_image] =>[orig_patent_app_number] => 11645289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886387 [patent_doc_number] => 20080260719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'EDG: Modulators of lymphocyte activation and migration' [patent_app_type] => utility [patent_app_number] => 11/636370 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 26346 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260719.pdf [firstpage_image] =>[orig_patent_app_number] => 11636370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92509 [patent_doc_number] => 07737259 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling' [patent_app_type] => utility [patent_app_number] => 11/565395 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 43843 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/737/07737259.pdf [firstpage_image] =>[orig_patent_app_number] => 11565395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4461173 [patent_doc_number] => 07879894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Use of anti-cytokine agents for treating carpal and tarsal tunnel syndrome' [patent_app_type] => utility [patent_app_number] => 11/563920 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5685 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879894.pdf [firstpage_image] =>[orig_patent_app_number] => 11563920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549291 [patent_doc_number] => 08324172 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same' [patent_app_type] => utility [patent_app_number] => 11/606368 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 41 [patent_no_of_words] => 26927 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11606368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5557758 [patent_doc_number] => 20090269335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'THERAPEUTIC AGENT FOR PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 12/094644 [patent_app_country] => US [patent_app_date] => 2006-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11678 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20090269335.pdf [firstpage_image] =>[orig_patent_app_number] => 12094644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8410315 [patent_doc_number] => 08273712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Promoting wound healing by administering a prostaglandin E and granulocyte-macrophage colony stimulating factor' [patent_app_type] => utility [patent_app_number] => 12/094322 [patent_app_country] => US [patent_app_date] => 2006-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 17865 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12094322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131561 [patent_doc_number] => 20070207958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Method of treatment of diabetes and/or obesity with reduced nausea side effect' [patent_app_type] => utility [patent_app_number] => 11/595576 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17046 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207958.pdf [firstpage_image] =>[orig_patent_app_number] => 11595576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5252801 [patent_doc_number] => 20070134257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Metal-binding therapeutic peptides' [patent_app_type] => utility [patent_app_number] => 11/595367 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 19879 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134257.pdf [firstpage_image] =>[orig_patent_app_number] => 11595367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6593575 [patent_doc_number] => 20100048466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance' [patent_app_type] => utility [patent_app_number] => 12/084498 [patent_app_country] => US [patent_app_date] => 2006-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 18998 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048466.pdf [firstpage_image] =>[orig_patent_app_number] => 12084498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4572010 [patent_doc_number] => 07858744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance' [patent_app_type] => utility [patent_app_number] => 11/591649 [patent_app_country] => US [patent_app_date] => 2006-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19004 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858744.pdf [firstpage_image] =>[orig_patent_app_number] => 11591649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5434887 [patent_doc_number] => 20090169473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'DIAGNOSTIC AGENT AND THERAPEUTIC AGENT FOR DISEASE ASSOCIATED WITH HEPATOCYTE GROWTH FACTOR RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/091299 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10543 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169473.pdf [firstpage_image] =>[orig_patent_app_number] => 12091299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5153902 [patent_doc_number] => 20070036785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Pharmaceutical composition for treatment of diseases caused by IL-6 production' [patent_app_type] => utility [patent_app_number] => 11/585172 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 7375 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20070036785.pdf [firstpage_image] =>[orig_patent_app_number] => 11585172 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4970709 [patent_doc_number] => 20070110711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Agent for enhancing the production of cytokines and/or chemokines' [patent_app_type] => utility [patent_app_number] => 11/583148 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8659 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20070110711.pdf [firstpage_image] =>[orig_patent_app_number] => 11583148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839372 [patent_doc_number] => 20080279857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Therapeutic Agent' [patent_app_type] => utility [patent_app_number] => 12/090635 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 20090 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279857.pdf [firstpage_image] =>[orig_patent_app_number] => 12090635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 277867 [patent_doc_number] => 07556941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-07 [patent_title] => 'Materials and methods for preparing dimeric growth factors' [patent_app_type] => utility [patent_app_number] => 11/550155 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12250 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/556/07556941.pdf [firstpage_image] =>[orig_patent_app_number] => 11550155 [rel_patent_id] =>[rel_patent_doc_number] =>)